Source: Pharmacy Times articles
Adherence to GLP-1 receptor agonists showed a 59% drop in inpatient hospital costs.
Read More
Recent Content
- How Cancer Care Teams Can Help With the Cessation of Smoking
- Asembia AXS25: Navigating the Transformative Landscape of GLP-1 Medications
- The Role of Physical Activity in Breast Cancer Risk Reduction and Survival
- B4DT Cognitive Behavioral Therapy Has Sustained Treatment Effects in Patients With Panic Disorders
- Coalition of Pharmacy Organizations Urges Congress to Pass ECAPS Legislation
- The OVATION 3 Study Initiates First Trial Site for Ovarian Cancer
- FDA Grants Fast Track Designation to IBS 2001, An Investigational Trispecific Antibody for Multiple Myeloma
- FDA Approves Avmapki Fakzynja Co-pack for KRAS Serous Ovarian Cancer
- Celebrating Nurses Week: The Heart and Soul of Our Cancer Community
- Neoadjuvant Trastuzumab Deruxtecan Improves Pathologic Complete Response in Patients With HER2+ Early Breast Cancer